Investor
Debiopharm Innovation Fund
Lausanne · Switzerland
A Swiss strategic investment fund focusing on digital health and smart data start-ups to improve patient outcomes in oncology and bacterial infections.
Stage
Seed–Series A
Sectors
Digital Health
Cheque
Not confirmed
Invests in
Global
Sectors
Digital Health
About
This Swiss firm maintains a commitment to improving patient outcomes through strategic investment. Its main activities encompass drug development, manufacturing, and digital health investment. The fund specifically targets digital health and smart data start-ups to establish future standards of care. These investments aim to cure cancer and infectious diseases while enhancing quality of life.
Portfolio · 5 · tap a company to read about it
Recent deals
- 2026-09Altis LabsSeries A
- 2026-07ViewsMLSeed
- 2025-03RaidiumSeed
- 2025-01Hope AISeed
- 2024-02StrategikonSeries ALed
- 2024-01MedaSystemsSeed
- 2023-06Altis LabsSeedLed
- 2023-06Altis LabsSeedLed
- 2023-03GenialisSeries A
- 2023-03IktosSeries A
- 2023-03IktosSeries ALed
- 2022-11YonaLinkGrowthLed
- 2022-11YonaLinkGrowth
- 2022-03VivoSenseSeries A
- 2022-03VivoSenseSeries ALed